Verona Pharma plans US public offering

Verona Pharma announces that it plans to conduct a registered initial public offering in the US.

The number of shares and price of the proposed offering have not yet been determined.

The proposed offering is expected to commence in the first half of 2017, after the US Securities and Exchange Commission completes its review process of the registration statement relating to the proposed offering and subject to market and other conditions.

At 9:33am: (LON:VRP) Verona Pharma PLC share price was 0p at 3.85p